Project Twenty21

Mike1

Project TWENTY21 will enrol 20,000 patients by the end of 2021, creating the largest body of evidence for the effectiveness and tolerability of medical cannabis – with an aim to demonstrate to policymakers that medical cannabis should be as widely available, and affordable, as other approved medicines for patients who would benefit from them.

In the first instance, this real-world registry will be targeting the following patients and situations, specifically focusing on those in which alternative treatment has failed:

Anxiety Disorder
Chronic Pain
Epilepsy
Multiple Sclerosis (MS)
Post Traumatic Stress Disorder (PTSD)
Substance Use Disorder (as a harm reduction strategy)
Tourette’s Syndrome

Treatment will be provided at a network of clinics across the UK which utilise best-practice in medical cannabis treatment from recognised global leaders in medical cannabis, including Canada and Australia.

If you are patient with one (or more) of the conditions named above, and wish to hear more about Project Twenty21, go to https://drugscience.org.uk/project-twenty21/ to register.

[Deleted User]

Thanks for posting this information Mike. Very interesting

Brynmor